← 返回

人源化患者来源卵巢癌异种移植模型

英文原题:Humanized Patient-Derived Xenograft Models of Ovarian Cancer.

查看英文原题

Humanized Patient-Derived Xenograft Models of Ovarian Cancer.

PubMed 2022/01/01(内容时间) Methods Mol Biol

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

癌症的体内建模是测试新型治疗策略以推进患者护理的关键步骤。在此,我们描述了如何开发一种人源化患者来源异种移植(PDX)卵巢癌模型,该模型利用原位移植的患者卵巢肿瘤,并自体转移扩增的肿瘤浸润T细胞(TILs),作为一种可用于在体内测试免疫调节治疗药物的模型。

展开英文摘要原文

In vivo modeling of cancer is a critical step in testing novel therapeutic strategies to advance patient care.

Here we describe how to develop a humanized patient-derived xenograft (PDX) model of ovarian cancer that uses orthotopically transplanted patient ovarian tumors with autologous transfer of expanded tumor infiltrating T cells (TILs) as a model that can be utilized to test immunomodulating therapeutics in vivo.

论文信息

作者
Gitto SB、George E、Medvedev S、Simpkins F、Powell DJ Jr
第一作者单位
Cancer Research Center, Division of Gynecology Oncology, Department of Obstetrics and Gynecology, Department of Pathology and Laboratory Medicine, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.United States
通讯作者单位
Cancer Research Center, Division of Gynecology Oncology, Department of Obstetrics and Gynecology, Department of Pathology and Laboratory Medicine, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. poda@pennmedicine.upenn.edu.United States
文献类型
美国 NIH 资助研究 · 非美国政府资助研究
期刊
Methods in molecular biology (Clifton, N.J.)2022
原文标识
PubMed 34918300 · DOI 10.1007/978-1-0716-1956-8_17